- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MK-6598
Total 1779 results
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Ireland, Australia, Israel, United Kingdom, Germany, Switzerland, Canada, Denmark, Poland
-
Merck Sharp & Dohme LLCCompleted
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Merck Sharp & Dohme LLCCompletedUrinary Incontinence
-
Merck Sharp & Dohme LLCCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
Merck Sharp & Dohme LLCCompletedLymphoma | Solid TumorUnited States, Israel
-
Chinese University of Hong KongRecruitingIVF | Reproductive Issues | SubfertilityHong Kong
-
Merck Sharp & Dohme LLCTerminatedHepatic Insufficiency | Antibacterial AgentsUnited States
-
Merck Sharp & Dohme LLCCompletedNeoplasms | Cancer | Metastatic Solid Tumors | Locally Advanced Tumors
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminatedPulmonary Arterial Hypertension
-
Merck Sharp & Dohme LLCCompletedDiabetes Mellitus, Type 2
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)TerminatedBrain and Central Nervous System TumorsUnited States
-
Vertex Pharmaceuticals IncorporatedCompletedCystic FibrosisUnited States, Spain, Australia, United Kingdom, Germany, Ireland
-
ALK-Abelló A/SMerck Sharp & Dohme LLCCompletedRhinitis, Allergic, Perennial | Rhinitis, Allergic, Nonseasonal
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)Alzheimer's Disease | Amnestic Mild Cognitive Impairment
-
Adam BrickmanNational Institute on Aging (NIA)Completed
-
Merck Sharp & Dohme LLCActive, not recruitingColorectal CancerUnited States, Poland, Belgium, Canada, Colombia, Costa Rica, Denmark, Estonia, France, Germany, Greece, Guatemala, Hungary, Italy, Korea, Republic of, Lithuania, Netherlands, Romania, Russian Federation, Spain, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCRecruitingRenal ImpairmentUnited States
-
Tammie L. S. Benzinger, MD, PhDEnrolling by invitation
-
Merck Sharp & Dohme LLCTerminatedRelapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Chronic Myelomonocytic LeukemiaUnited States, Israel, Spain
-
Merck Sharp & Dohme LLCCompletedHepatic ImpairmentUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCCompletedPANCREAS | NeuroendocrineUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Akebia TherapeuticsCompleted
-
Merck Sharp & Dohme LLCCompletedModerate Renal ImpairmentUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCTerminatedNeoplasms | Head and Neck Neoplasms | Colorectal NeoplasmsAustralia, Hong Kong
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminatedPulmonary Hypertension | Left Heart Disease
-
Chinese University of Hong KongCompleted
-
Dana-Farber Cancer InstituteMemorial Sloan Kettering Cancer Center; Massachusetts General Hospital; University... and other collaboratorsWithdrawn
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCWithdrawn
-
Merck Sharp & Dohme LLCNot yet recruitingHepatic Impairment (HI)
-
Merck Sharp & Dohme LLCRecruitingBipolar I DisorderUnited States
-
Merck Sharp & Dohme LLCRecruitingNon-segmental VitiligoUnited States, Canada, Australia, Korea, Republic of, Switzerland, Germany, Spain, Chile, France, Israel, Netherlands, Japan, Belgium, Argentina, United Kingdom
-
Merck Sharp & Dohme LLCNot yet recruiting
-
National Human Genome Research Institute (NHGRI)Recruiting